Personalised targeted medicine

A. Agusti Garcia-Navarro (Barcelona, Spain)

Source: Research Seminar 2015 - Personalising respiratory care in Europe
Number: 12

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Agusti Garcia-Navarro (Barcelona, Spain). Personalised targeted medicine. Research Seminar 2015 - Personalising respiratory care in Europe

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Personalised medicine in asthma: from curative to preventive medicine
Source: Eur Respir Rev 2017; 26: 160010
Year: 2017



Personalised medicine: are we ready?
Source: Eur Respir Rev, 26 (145) 170088; 10.1183/16000617.0088-2017
Year: 2017



Personalised medicine: how ready are we for this?
Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare
Year: 2013


Talk from Lisbon – Personalised medicine: an approach to holistic care
Source: ERS Satellites 2019
Year: 2019

Personalised medicine in asthma: time for action
Source: Eur Respir Rev, 26 (145) 170064; 10.1183/16000617.0064-2017
Year: 2017



What is evidence-based medicine?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006



Personalised medicine through individual approaches to resolve lung injury
Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment
Year: 2021


Personalised medicine through biological subphenotyping of ARDS
Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment
Year: 2021

Personalised medicine: a step forward to better care?
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013



Personalised medicine in paediatric asthma, including from the patient's perspective
Source: International Congress 2016 – PG8 Paediatric asthma
Year: 2016


The contribution of evidence-based medicine
Source: Annual Congress 2004 - PG17 - How to conduct a scientific survey on respiratory health
Year: 2004


The future of personalised medicine in COPD
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


The impact of personalised therapies on respiratory medicine
Source: Eur Respir Rev 2013; 22: 72-74
Year: 2013



Biomarkers and personalised medicine for asthma
Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018
Year: 2019



Personalised medicine in exacerbations of COPD: the beginnings
Source: Eur Respir J 2012; 40: 1318-1319
Year: 2012


Personalised medicine in interstitial lung diseases
Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017
Year: 2018